Sign in
4

Changes in Ownership

NEKTAR THERAPEUTICS Filed Acc 0001209191-20-049782

Director acquired 30,000 shares (option exercise)

From the SEC's structured data for this filing

Trades in this filing

WHITFIELD ROY A · Director

Table I: Non-derivative

1 line
Date Transaction Shares Price Value Owned after D/I
2020-09-04 Exercise or conversion : show line 1 in the form +30,000 $9.24 $277,200 228,250 D

Table II: Derivative

1 line
Date Transaction Shares Owned after D/I
2020-09-04 Exercise or conversion : show line 2 in the form Stock Option −30,000 0 D
Loading xslF345X03/doc4.xml…